In summary, our study demonstrated that disruption of CCR5 using CRISPR/SaCas9 delivered by lentivirus in human primary CD4+ T cells resulted in T-cell prevention of HIV-1 infection and enrichment in humanized mice. This evidence concerns the gene CCR5 and HIV-1 infection.